/

Obsidian Therapeutics

Develops engineered cell and gene therapies for cancer treatment.

BiotechnologyPharmaceuticals obsidiantx.com ↗

Company facts

Founded: 2015
Employees: 96
Headquarters: United States
Type: Private
Funding: Series C · $160.5M · 2024